37
Participants
Start Date
October 31, 2011
Primary Completion Date
May 31, 2016
Study Completion Date
March 5, 2021
RT-CGM
Each device is approximately the size of a pager and transmits with a subcutaneously placed sensor consisting of a 21 - 26 gauge needle 5 - 12 mm in length. Sensors are placed using sterile precautions and changed every 3 - 7 days depending on the manufacturers' instructions. All devices are approved as adjunctive tools to blood glucose monitoring that will be continued at least 4 times daily, before each meal and at bedtime.
Clinical and Translational Research Center, Hospital of University of Pennsylvania, Philadelphia
Rodebaugh Diabetes Center, University of Pennsylvania, Philadelphia
University of Pennsylvania - Institute for Diabetes, Obesity and Metabolism, Philadelphia
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
NIH
University of Pennsylvania
OTHER